ES-PROZOLE 40 TAB - Dr Precision

81.00

81.00

Inclusive of all taxes

You Save: 0. Discount 0%

  • Product is not available

Availability: In Stock

ES-PROZOLE 40 TAB is a high-quality proton pump inhibitor (PPI) formulation containing Esomeprazole 40 mg, clinically indicated for the management of acid reflux, GERD, peptic ulcers, and erosive esophagitis. Developed and manufactured by BluepillExpress, this enteric-coated tablet delivers optimal acid suppression, promotes healing of gastric mucosa, and relieves heartburn and acid-related symptoms. ES-PROZOLE 40 is a dependable solution for third-party manufacturing, institutional supply, or pharma export across regulated and semi-regulated markets.


This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.


  • Additional Information

    ES-PROZOLE 40 TAB, from the expert manufacturing house of BluepillExpress, is a therapeutic-grade oral formulation of Esomeprazole, the S-isomer of omeprazole. It belongs to the class of proton pump inhibitors (PPIs) and provides effective and long-lasting suppression of gastric acid secretion by selectively blocking the H+/K+ ATPase enzyme system in gastric parietal cells.


    Esomeprazole 40 mg is widely prescribed for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, Zollinger-Ellison syndrome, and for NSAID-induced ulcer prophylaxis. Its delayed-release design ensures targeted action in the intestines, enhancing absorption and bioavailability while minimizing gastric degradation.


    Backed by WHO-GMP certified production facilities, ES-PROZOLE 40 TAB guarantees high pharmaceutical standards, consistency in every batch, and optimal shelf stability. This product is ideal for pharmaceutical distributors, hospital tenders, healthcare chains, and international buyers seeking quality-assured gastroenterological medicines.


    ✅ Therapeutic Uses

    Gastroesophageal Reflux Disease (GERD)


    Erosive Esophagitis


    Peptic Ulcer Disease (PUD)


    Helicobacter pylori eradication regimens (as part of triple therapy)


    NSAID-associated gastric ulcers and prevention


    Zollinger-Ellison Syndrome


    Functional Dyspepsia


    ✅ Mechanism of Action

    Esomeprazole irreversibly inhibits the H+/K+ ATPase (proton pump) on gastric parietal cells, the final step of acid secretion. This leads to prolonged reduction of stomach acid production and provides symptomatic relief from acid reflux and heartburn while promoting healing of gastric mucosa.


    ✅ Dosage & Administration

    Standard dose: 1 tablet (40 mg) once daily


    In GERD and erosive esophagitis: 4 to 8 weeks therapy recommended


    Take at least 1 hour before meals for best effect


    Dosage may be adjusted based on severity and clinical judgment


    ✅ Pharmacokinetics

    Bioavailability: Approximately 90% after repeated doses


    Onset of Action: Within 1 hour


    Half-life: 1.3 hours


    Metabolism: Hepatic via CYP2C19 and CYP3A4


    Excretion: Renal and biliary

  • Reviews ()

    Please login to write a review
    Log In